U.S. Markets open in 7 hrs 33 mins

Sanofi (SAN.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
82.76+0.18 (+0.22%)
At close: 5:35PM CEST
People also watch
FP.PABN.PACS.PAOR.PAAI.PA
Full screen
Previous Close82.58
Open82.42
Bid71.12 x 1000
Ask71.74 x 44000
Day's Range82.30 - 83.26
52 Week Range66.72 - 92.97
Volume2,028,464
Avg. Volume2,365,474
Market Cap101.09B
Beta0.74
PE Ratio (TTM)11.45
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield3.30 (3.49%)
Ex-Dividend Date2017-05-16
1y Target EstN/A
  • EpiPen maker finalizes settlement for government overcharges
    Associated Press10 hours ago

    EpiPen maker finalizes settlement for government overcharges

    TRENTON, N.J. (AP) — EpiPen maker Mylan has finalized a $465 million government agreement settling allegations it overbilled Medicaid for its emergency allergy injectors for a decade — charges brought after rival Sanofi filed a whistleblower lawsuit and tipped off the government.

  • American City Business Journals13 hours ago

    EpiPen maker settles federal claims for $465M a year after Sanofi filed suit

    Mylan NV will pay $465 million fine to settle claims brought by the U.S. Justice Department that it overcharged the government for its emergency allergy drug, EpiPen. French drug company Sanofi, the parent company of the state’s largest biotech employer, Sanofi Genzyme (SNY), first brought the matter to the attention of the U.S. Attorney’s Office in 2014 because it was selling a competing epinephrine auto-injector drug called AUVI-Q. In 2016, Sanofi filed a complaint in Massachusetts federal court against Mylan under the False Claims Act, which permits private parties to sue on behalf of the government and to receive a share of any recovery.

  • TheStreet.com13 hours ago

    Mylan Finalizes $465 Million EpiPen Settlement With DoJ

    The dispute became the center of a drug price firestorm.